VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2020 | Updates on ropeginterferon in PV

VJHemOnc is committed to improving our service to you

Jean-Jacques Kiladjian

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, discusses the results of PROUD-PV (NCT01949805) and CONTINUATION-PV (NCT02218047) studies investigating the use of ropeginterferon alfa-2b in low-risk polycythemia vera patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter